Monash wins for Research Commercialisation at AFR Higher Education Awards

L-R: Dr Gregory Stewart and Professor Chris Langmead.

20 August 2025

The team behind Monash University’s Neuromedicines Discovery Centre (NDC) have been named the joint winners of the Research Commercialisation Award in the 2025 Australian Financial Review’s (AFR) Higher Education Awards.

Professor Chris Langmead and Dr Gregory Stewart (pictured) represented the NDC team who has won for their outstanding work in establishing new partnerships and start-ups to help address the urgent unmet need for new mental health and neurological medicines.

Alongside leading researchers from the Monash Institute of Pharmaceutical Sciences, the Florey Institute of Neuroscience and Mental Health and industry, NDC co-founder Professor Langmead and team have played an integral role in spearheading the establishment of NDC spinouts Phrenix Therapeutics and Pacalis Therapeutics.

To read the full article, visit here.